Evaluation of golimumab for the treatment of patients with active rheumatoid arthritis

Keywords

Golimumab, Rheumatoid arthritis, Medicine, Methotrexate, Pharmacokinetics

References

• Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab.Jenne M. Westberry — 2008
• [Pharmacological and clinical profile of golimumab (Simponi®)].Hideji Fujii, Yoshinori Murakami, Yasushi Harada — 2013
• High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR*Robert L. Shields, Angela K. Namenuk, Kyu Hong — 2001
• How tumour necrosis factor blockers interfere with tuberculosis immunityJames Harris, Joseph Keane — 2010
• Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab befPaul Emery, Roy Fleischmann, Larry W. Moreland — 2009
• The benefit/risk profile of TNF-blocking agents: findings of a consensus panel.Marc C. Hochberg, Mark Lebwohl, Scott E. Plevy — 2005
• The IgG Fc receptor familyJohannes Gessner, Hans Heiken, Anu Tamm — 1998
• Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.Peter C. Taylor — 2010
• Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor.Zehra Kaymakcalan, Paul Sakorafas, Sahana Bose — 2009
• Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor αDavid J. Shealy, Ann Cai, Kim Staquet — 2010
• Golimumab pharmacokinetics after repeated subcutaneous and intravenous administrations in patients with rheumatoid arthritis and the effect of concomitant methotrexate: an open-label, randomized study.Yanli Zhuang, Zhenhua Xu, Bart Frederick — 2012
• High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice.Dianne M. Fishwild, Susan L. O'Donnell, Tasha Bengoechea — 1996
• Elimination mechanisms of therapeutic monoclonal antibodies.Mohammad Tabrizi, Chih-Ming L. Tseng, Lorin Roskos — 2006
• Transcytosis and catabolism of antibodyVictor Gheţie, E. Sally Ward — 2002
• The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy.Paul Emery, Roy Fleischmann, Désirée van der Heijde — 2011
• Human antibodies from transgenic animalsNils Lönberg — 2005
• Antibody pharmacokinetics and pharmacodynamics.Evelyn D. Lobo, Ryan J. Hansen, Joseph P. Balthasar — 2004
• Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis.D. van der Heijde, PietL Van Riel, F. W. J. Gribnau — 1989
• Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases.R. Pérez-Álvarez, M. Pérez-de-Lis, Cándido Díaz‐Lagares — 2011
• Golimumab in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results Through 2 Years of the GO-FORWARD Study ExtensionEdward Keystone, Mark C. Genovese, Stephen Hall — 2013

Cited by

• ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents).John W. Baddley, Fabrizio Cantini, Delia Goletti — 2018
• Dose Adjustment of Methotrexate Administered Concomitantly with Golimumab for Rheumatoid Arthritis in Japanese Real-World Clinical SettingsFumiko Yamairi, Toshiro Yano, Takashi Goto — 2020
• Rheumatoid arthritis: advances in treatment strategiesPeeyush Prasad, Sneha Verma, Surbhi — 2022
• Persistence and Safety of Golimumab in Elderly Patients with Rheumatoid Arthritis and Renal Dysfunction in a Real-World SettingSeiji Yokoyama, Yutaka Ishii, Junya Masuda — 2022
• Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV InfectionTing Xue, Xiaomei Kong, Liang Ma — 2023
• Safety and Efficacy of Golimumab in Rheumatoid Arthritis: A Prospective, Multicenter, Real-World Study from IndiaBimlesh Dhar Pandey, Venkataraman Krishnamurthy, Uma Kumar — 2023
• Abatacept, Golimumab, and Sarilumab as Selected Bio-Originator Disease-Modifying Antirheumatic Drugs with Diverse Mechanisms of Action in Their Current Use in TreatmentPiotr Kawczak, Igor Feszak, Tomasz Bączek — 2025
• Efficacy and Safety of Biosimilar AVT05 Versus Reference Product Golimumab in Combination with Methotrexate in Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results of a Randomized, Parallel-Group, Double-Blind StudyMónica Luque, Kristina Zhelyazkova, Laxmikant Vashishta — 2025

Related papers

• Golimumab: In Combination with Methotrexate as Once Monthly Treatment for Moderate to Severe Rheumatoid ArthritisLauren Keyser Mccluggage, Kelly Michelle Chisholm — 2011
• HSD133 Factors Influencing Selection of First Add-on Disease-Modifying Therapy for Rheumatoid Arthritis after Starting MethotrexateYixuan Huang, Suneal Agarwal, H Chen — 2022
• Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapyByung-Ryul Choi, Myung‐Ju Ahn, Woong Soo Lee — 2005
• Intrarticular methotrexate in the therapy of rheumatoid arthritis.Federico Franchi, P Seminara, Giovanni Codacci-Pisanelli — 1989
• Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone.Antonio Marchesoni — 2003
• Methotrexate in Treatment of Rheumatoid ArthritisMaciej Wiewiόrowski, Julita Graczyl — 1999
• Effect of Methotrexate on Probable Rheumatoid ArthritisZhu Tie-chu — 2008
• What to Add When Methotrexate Fails in Rheumatoid Arthritis PatientsAllan S. Brett — 2013
• Leflunomide combined with methotrexate in treatment of Rheumatoid ArthritisXuejun Hu, Gang Liang, Yuting Wang — 2014